Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Glycan Engineering for Cell and Developmental Biology.

Griffin ME, Hsieh-Wilson LC.

Cell Chem Biol. 2016 Jan 21;23(1):108-21. doi: 10.1016/j.chembiol.2015.12.007. Review.

PMID:
26933739
2.

Prenatal muscle development in a mouse model for the secondary dystroglycanopathies.

Kim J, Hopkinson M, Kavishwar M, Fernandez-Fuente M, Brown SC.

Skelet Muscle. 2016 Feb 19;6:3. doi: 10.1186/s13395-016-0073-y. eCollection 2015.

3.

Mapping the O-Mannose Glycoproteome in Saccharomyces cerevisiae.

Neubert P, Halim A, Zauser M, Essig A, Joshi HJ, Zatorska E, Larsen IS, Loibl M, Castells-Ballester J, Aebi M, Clausen H, Strahl S.

Mol Cell Proteomics. 2016 Apr;15(4):1323-37. doi: 10.1074/mcp.M115.057505. Epub 2016 Jan 13.

4.

ISPD mutations account for a small proportion of Italian Limb Girdle Muscular Dystrophy cases.

Magri F, Colombo I, Del Bo R, Previtali S, Brusa R, Ciscato P, Scarlato M, Ronchi D, D'Angelo MG, Corti S, Moggio M, Bresolin N, Comi GP.

BMC Neurol. 2015 Sep 24;15:172. doi: 10.1186/s12883-015-0428-8.

5.

Hansenula polymorpha Pmt4p Plays Critical Roles in O-Mannosylation of Surface Membrane Proteins and Participates in Heteromeric Complex Formation.

Kim H, Thak EJ, Lee DJ, Agaphonov MO, Kang HA.

PLoS One. 2015 Jul 2;10(7):e0129914. doi: 10.1371/journal.pone.0129914. eCollection 2015.

6.

Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane.

Yoshida-Moriguchi T, Campbell KP.

Glycobiology. 2015 Jul;25(7):702-13. doi: 10.1093/glycob/cwv021. Epub 2015 Apr 16. Review.

7.

Neurons and glia modify receptor protein-tyrosine phosphatase ζ (RPTPζ)/phosphacan with cell-specific O-mannosyl glycans in the developing brain.

Dwyer CA, Katoh T, Tiemeyer M, Matthews RT.

J Biol Chem. 2015 Apr 17;290(16):10256-73. doi: 10.1074/jbc.M114.614099. Epub 2015 Mar 3.

8.

Morphological and functional aspects of progenitors perturbed in cortical malformations.

Bizzotto S, Francis F.

Front Cell Neurosci. 2015 Feb 12;9:30. doi: 10.3389/fncel.2015.00030. eCollection 2015. Review.

9.

Fukutin is prerequisite to ameliorate muscular dystrophic phenotype by myofiber-selective LARGE expression.

Ohtsuka Y, Kanagawa M, Yu CC, Ito C, Chiyo T, Kobayashi K, Okada T, Takeda S, Toda T.

Sci Rep. 2015 Feb 9;5:8316. doi: 10.1038/srep08316.

10.

Genetic, chromosomal, and syndromic causes of neural tube defects.

Seidahmed MZ, Abdelbasit OB, Shaheed MM, Alhussein KA, Miqdad AM, Samadi AS, Khalil MI, Al-Mardawi E, Salih MA.

Saudi Med J. 2014 Dec;35 Suppl 1:S49-56.

11.

Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.

Inamori K, Willer T, Hara Y, Venzke D, Anderson ME, Clarke NF, Guicheney P, Bönnemann CG, Moore SA, Campbell KP.

J Biol Chem. 2014 Oct 10;289(41):28138-48. doi: 10.1074/jbc.M114.597831. Epub 2014 Aug 19.

12.

Finding the sweet spot: assembly and glycosylation of the dystrophin-associated glycoprotein complex.

Townsend D.

Anat Rec (Hoboken). 2014 Sep;297(9):1694-705. doi: 10.1002/ar.22974. Review.

13.

Role of glycosyltransferase PomGnT1 in glioblastoma progression.

Lan J, Guo P, Lin Y, Mao Q, Guo L, Ge J, Li X, Jiang J, Lin X, Qiu Y.

Neuro Oncol. 2015 Feb;17(2):211-22. doi: 10.1093/neuonc/nou151. Epub 2014 Aug 1.

14.

Muscle and heart function restoration in a limb girdle muscular dystrophy 2I (LGMD2I) mouse model by systemic FKRP gene delivery.

Qiao C, Wang CH, Zhao C, Lu P, Awano H, Xiao B, Li J, Yuan Z, Dai Y, Martin CB, Li J, Lu Q, Xiao X.

Mol Ther. 2014 Nov;22(11):1890-9. doi: 10.1038/mt.2014.141. Epub 2014 Jul 22.

15.

POMK mutations disrupt muscle development leading to a spectrum of neuromuscular presentations.

Di Costanzo S, Balasubramanian A, Pond HL, Rozkalne A, Pantaleoni C, Saredi S, Gupta VA, Sunu CM, Yu TW, Kang PB, Salih MA, Mora M, Gussoni E, Walsh CA, Manzini MC.

Hum Mol Genet. 2014 Nov 1;23(21):5781-92. doi: 10.1093/hmg/ddu296. Epub 2014 Jun 11.

16.

Genetic basis of limb-girdle muscular dystrophies: the 2014 update.

Nigro V, Savarese M.

Acta Myol. 2014 May;33(1):1-12. Review.

17.

Mammalian O-mannosylation pathway: glycan structures, enzymes, and protein substrates.

Praissman JL, Wells L.

Biochemistry. 2014 May 20;53(19):3066-78. doi: 10.1021/bi500153y. Epub 2014 May 7. Review.

18.

Adeno-associated virus-mediated overexpression of LARGE rescues α-dystroglycan function in dystrophic mice with mutations in the fukutin-related protein.

Vannoy CH, Xu L, Keramaris E, Lu P, Xiao X, Lu QL.

Hum Gene Ther Methods. 2014 Jun;25(3):187-96. doi: 10.1089/hgtb.2013.151. Epub 2014 May 2.

19.

Protein O-mannosylation in metazoan organisms.

Panin VM, Wells L.

Curr Protoc Protein Sci. 2014 Feb 3;75:Unit 12.12.. doi: 10.1002/0471140864.ps1212s75.

20.

A novel missense mutation in POMT1 modulates the severe congenital muscular dystrophy phenotype associated with POMT1 nonsense mutations.

Wallace SE, Conta JH, Winder TL, Willer T, Eskuri JM, Haas R, Patterson K, Campbell KP, Moore SA, Gospe SM Jr.

Neuromuscul Disord. 2014 Apr;24(4):312-20. doi: 10.1016/j.nmd.2014.01.001. Epub 2014 Jan 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk